Back
Relay Therapeutics Quote, Financials, Valuation and Earnings
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
RLAY
Relay Therapeutics
Last Price:
7.85
Seasonality Move:
-5.33%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Relay Therapeutics Price Quote
$7.85
+0.27 (+3.56%)
(Updated: September 19, 2024 at 3:50 PM ET)
Relay Therapeutics Key Stats
Sell
31
Relay Therapeutics (RLAY)
is a Sell
Day range:
$7.45 - $7.89
52-week range:
$5.70 - $12.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
27.39
P/B ratio:
1.49%
Volume:
1.5M
Avg. volume:
2.5M
1-year change:
-15.78%
Market cap:
$1B
Revenue:
$25.5M
EPS:
$-2.52
How Much Does Relay Therapeutics Make?
Data Unavailable
Is Relay Therapeutics Growing As A Company?
Data Unavailable
Relay Therapeutics Stock Price Performance
-
Did Relay Therapeutics Stock Go Up Last Month?
Relay Therapeutics share price went up by 17.52% last month -
Did RLAY's Share Price Rise Over The Last Year?
RLAY share price fell by -15.78% over the past 1 year
What Is Relay Therapeutics 52-Week High & Low?
-
What Is Relay Therapeutics’s 52-Week High Share Price?
Relay Therapeutics has traded as high as $12.14 over the past 52 weeks -
What Is Relay Therapeutics’s 52-Week Low Share Price?
Relay Therapeutics has traded as low as $5.70 over the past 52 weeks
Relay Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Relay Therapeutics?
-
How Much Debt Does Relay Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Relay Therapeutics Have?
Cash and short term investments quarterly total is $688.4M -
What Is Relay Therapeutics’s Book Value Per Share?
Book value per share is 5.11
Is Relay Therapeutics Cash Flow Positive?
-
What Is RLAY Cash Flow From Operations?
Cash flow from operations (TTM) is -$280.7M -
What Is Relay Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $81.8M -
What Is Relay Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $187.1M
Relay Therapeutics Return On Invested Capital
Data Unavailable
Relay Therapeutics Earnings Date & Stock Price
-
What Is Relay Therapeutics's Stock Price Today?
A single share of RLAY can be purchased today for 7.58 -
What Is Relay Therapeutics’s Stock Symbol?
Relay Therapeutics trades on the nasdaq under the ticker symbol: RLAY -
When Is Relay Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Relay Therapeutics is scheduled on November 1, 2024 -
When Is RLAY's next ex-dividend date?
Relay Therapeutics's next ex-dividend date is September 19, 2024 -
How To Buy Relay Therapeutics Stock?
You can buy Relay Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Relay Therapeutics Competitors
-
Who Are Relay Therapeutics's Competitors?
Below is a list of companies who compete with Relay Therapeutics or are related in some way:
Relay Therapeutics Dividend Yield
-
What Is RLAY Dividend Yield?
Relay Therapeutics’s dividend yield currently is 0% -
What Is Relay Therapeutics’s Payout Ratio?
Relay Therapeutics’s payout ratio is 0% -
When Did Relay Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Relay Therapeutics’s Dividend Per Share?
Relay Therapeutics pays a dividend of $0.00 per share
Relay Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 5.64% |
| Revenue: | 0% | -100% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 22.30 |
| Upside from Last Price: | 194.2% |